Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation
Authors
Keywords
-
Journal
LEUKEMIA
Volume 29, Issue 1, Pages 137-144
Publisher
Springer Nature
Online
2014-06-03
DOI
10.1038/leu.2014.173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Similar Overall Survival Using Sibling, Unrelated Donor, and Cord Blood Grafts after Reduced-Intensity Conditioning for Older Patients with Acute Myelogenous Leukemia
- (2013) Régis Peffault de Latour et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- How I assess comorbidities before hematopoietic cell transplantation
- (2013) M. L. Sorror BLOOD
- Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission
- (2013) R. B. Walter et al. BLOOD
- Achieving stringent CR is essential before reduced-intensity conditioning allogeneic hematopoietic cell transplantation in AML
- (2013) C Ustun et al. BONE MARROW TRANSPLANTATION
- Long-term survival after allogeneic haematopoietic cell transplantation for AML in remission: single-centre results after TBI-based myeloablative and non-myeloablative conditioning
- (2013) H Sengeløv et al. BONE MARROW TRANSPLANTATION
- Long-term survival with low toxicity after allogeneic transplantation for acute myeloid leukaemia and myelodysplasia using non-myeloablative conditioning without T cell depletion
- (2013) Jeff K. Davies et al. BRITISH JOURNAL OF HAEMATOLOGY
- Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemia
- (2012) W. Leung et al. BLOOD
- Comparison of conditioning regimens of various intensities for allogeneic hematopoietic SCT using HLA-identical sibling donors in AML and MDS with
- (2012) R Martino et al. BONE MARROW TRANSPLANTATION
- Prognostic and therapeutic implications of minimal residual disease at the time of transplantation in acute leukemia
- (2012) S A Buckley et al. BONE MARROW TRANSPLANTATION
- Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation
- (2012) F Baron et al. LEUKEMIA
- The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
- (2012) Jan J. Cornelissen et al. Nature Reviews Clinical Oncology
- Concise Review: The Role of Hematopoietic Stem Cell Transplantation in the Treatment of Acute Myeloid Leukemia
- (2012) Betty K. Hamilton et al. STEM CELLS
- High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia
- (2011) W. Leung et al. BLOOD
- Prognostic impact of discordant results from cytogenetics and flow cytometry in patients with acute myeloid leukemia undergoing hematopoietic cell transplantation
- (2011) Min Fang et al. CANCER
- Impact of Pretransplantation Minimal Residual Disease, As Detected by Multiparametric Flow Cytometry, on Outcome of Myeloablative Hematopoietic Cell Transplantation for Acute Myeloid Leukemia
- (2011) Roland B. Walter et al. JOURNAL OF CLINICAL ONCOLOGY
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- Long-term disease-free survival after nonmyeloablative cyclophosphamide/fludarabine conditioning and related/unrelated allotransplantation for acute myeloid leukemia/myelodysplasia
- (2010) R P Nelson et al. BONE MARROW TRANSPLANTATION
- Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia
- (2010) Boglarka Gyurkocza et al. JOURNAL OF CLINICAL ONCOLOGY
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
- (2009) J. W. Vardiman et al. BLOOD
- HighWT1gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival
- (2009) David A. Jacobsohn et al. BRITISH JOURNAL OF HAEMATOLOGY
- Toward Optimization of Postremission Therapy for Residual Disease–Positive Patients With Acute Myeloid Leukemia
- (2008) Luca Maurillo et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now